Exodus Point Capital Management, LP Blueprint Medicines Corp Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 91,636 shares of BPMC stock, worth $8.47 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
91,636
Previous 21,041
335.51%
Holding current value
$8.47 Million
Previous $2 Million
394.84%
% of portfolio
0.07%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$614 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$604 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$543 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$299 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$227 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.52B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...